Chemical Structure : Dacetuzumab
CAS No.: 880486-59-9
货号: PC-Ab1099Not For Human Use, Lab Use Only.
Dacetuzumab (SGN-40, huS2C6) is a humanized anti-CD40 monoclonal antibody that specifically binds to and works against a molecule called a CD40 receptor. Dacetuzumab has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin Lymphoma, Leukemia, Lymphocytic, Chronic, and Lymphoma, Large B-Cell, Diffuse. It is a humanized anti-CD40 antibody and induces cytotoxicity in human multiple myeloma cells. Dacetuzumab demonstrated antitumor activity in relapsed/refractory diffuse large
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥3580 | In stock | |
| 5 mg | ¥7580 | In stock | |
| 10 mg | ¥12800 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Dacetuzumab (SGN-40, huS2C6) is a humanized anti-CD40 monoclonal antibody that specifically binds to and works against a molecule called a CD40 receptor. Dacetuzumab has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin Lymphoma, Leukemia, Lymphocytic, Chronic, and Lymphoma, Large B-Cell, Diffuse. It is a humanized anti-CD40 antibody and induces cytotoxicity in human multiple myeloma cells. Dacetuzumab demonstrated antitumor activity in relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Dacetuzumab induces ADCC and ADCP via interaction with Fc receptors on T cells, NK cells, monocytes, and macrophages.
| 分子量 | ||
| 分子式 | Human IgG1-Kappa | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             PBS, pH 7.0 Contains no stabilizers or preservatives  | 
                    |
| Chemical Name/SMILES | 
                             Dacetuzumab; SGN-40; SGN40; huS2C6; SEA-40; 880486-59-9; Cluster of Differentiation 40; CD40/TNFR5; Anti-human CD40  | 
                    |
1. 1, Lewis TS, et al. Clin Cancer Res. 2011 Jul 15;17(14):4672-81. 2, Lewis TS, et al. Leukemia. 2011 Jun;25(6):1007-16. 3, Huang EP, et al. BMC Cancer. 2010 Oct 27;10:586. 4, Burington B, et al. Sci Transl Med. 2011 Mar 16;3(74):74ra22.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright